Your browser doesn't support javascript.
loading
p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.
Yogev, Orli; Barker, Karen; Sikka, Arti; Almeida, Gilberto S; Hallsworth, Albert; Smith, Laura M; Jamin, Yann; Ruddle, Ruth; Koers, Alexander; Webber, Hannah T; Raynaud, Florence I; Popov, Sergey; Jones, Chris; Petrie, Kevin; Robinson, Simon P; Keun, Hector C; Chesler, Louis.
Afiliação
  • Yogev O; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Barker K; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Sikka A; Department of Surgery and Cancer, Imperial College, London, United Kingdom.
  • Almeida GS; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom. Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
  • Hallsworth A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Smith LM; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
  • Ruddle R; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
  • Koers A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Webber HT; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Raynaud FI; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
  • Popov S; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Department of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
  • Jones C; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Department of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
  • Petrie K; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Robinson SP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
  • Keun HC; Department of Surgery and Cancer, Imperial College, London, United Kingdom.
  • Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom. louis.chesler@icr.ac.uk.
Cancer Res ; 76(10): 3025-35, 2016 05 15.
Article em En | MEDLINE | ID: mdl-27197232
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Adaptação Fisiológica / Proteína Supressora de Tumor p53 / Apoptose / Proteína Proto-Oncogênica N-Myc / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Adaptação Fisiológica / Proteína Supressora de Tumor p53 / Apoptose / Proteína Proto-Oncogênica N-Myc / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article